News That Matters

Tag: older

Drug offers hope for acute myeloid leukemia treatment in older adults

Drug offers hope for acute myeloid leukemia treatment in older adults

Health
Dec. 24 (UPI) -- A new drug for acute myeloid leukemia, or AML, improves overall survival in people with the deadly blood cancer by up to 10 months, according to the results of a Phase 3 clinical trial published Thursday by the New England Journal of Medicine. In a study conducted at 148 hospitals in 23 countries, the drug, called CC-486, improved survival in patients age 55 and older, the data showed. Advertisement Those given the medication, a tablet formulation of the drug azacitidine, had an average survival from remission of almost 25 months, compared to 15 months for patients who did not take the drug. The U.S. Food and Drug Administration approved CC-486 in September. "It is very exciting to think that, by taking a tablet that is relatively well-tolerated, we can help reduce relap...
Oxford vaccine produces strong immune response in older adults, early results show

Oxford vaccine produces strong immune response in older adults, early results show

Technology
The COVID-19 vaccine developed by Oxford University produces a strong immune response in older adults, data from early trials has shown.The phase one and phase two results suggest that one of the groups most at risk of death or serious illness from COVID-19 may be able to build immunity, according to data published in The Lancet medical journal. It comes a day after Pfizer announced its coronavirus vaccine was 94% effective among adults over 65 in its final efficacy results, and that it would be seeking authorisation over the next few days.Live coronavirus updates from the UK and around the world Please use Chrome browser for a more accessible video player ...
Opioid use increases risk of death in older adults after outpatient surgery, study says

Opioid use increases risk of death in older adults after outpatient surgery, study says

Health
Oct. 21 (UPI) -- Older adults who used opioid pain medications before minor surgery were up to 68% more likely to die within 90 days of the procedure compared with those who never used the drugs, an analysis published Wednesday by JAMA Surgery found. Even among people older than 65 who had low levels of opioid use as long as eight months before surgery, about 55 people per 10,000 in the general population died within 90 days of having a procedure, the data showed. Advertisement Older adults who had not used opioid pain drugs prior to surgery died at a rate of just over 40 per 10,000 in the general population within 90 days of having a minor procedure, the researchers said. "People who have preoperative exposure to opioids have a higher risk of mortality after outpatient surgery," study co...
Survey: Front-line health workers, kids, older adults should get COVID-19 vaccine first

Survey: Front-line health workers, kids, older adults should get COVID-19 vaccine first

Health
Sept. 29 (UPI) -- Front-line healthcare workers, children and older adults should receive priority if or when a COVID-19 vaccine is available, according to the result of a survey of U.S. adults published Tuesday by JAMA Network Open. Ninety-two percent of respondents indicated that front-line clinicians treating patients infected with the new coronavirus should be vaccinated first, while 81% said younger people and seniors need to be at or near the top of the list, the data showed. Advertisement Since the start of the pandemic, health workers and older adults have been at increased risk for infection compared to other demographic groups. Although children generally have lower risk, youngsters who are infected face the possibility serious complications, including Kawasaki-like disease. "O...
Older people excluded from coronavirus trials, study warns

Older people excluded from coronavirus trials, study warns

Technology
Older people are being excluded from the vast majority of trials to find treatments and a vaccine for COVID-19, according to a study.Around 9% of the global population is 65 and older, but this demographic has accounted for up to 40% of coronavirus cases and 80% of deaths. People in that age group were reported as absent from half of US trials for COVID-19 treatments, and all of the vaccine trials, researchers found.It raises the risk that treatments won't be suitable for those hit hardest by the pandemic. The figures come from clinical trials registered with the US government between 1 October 2019 and 1 June 2020. ...